Sample pages — preview before you buy

Judge the quality before you commit.

Real excerpts from the certificate course and Clinical Operations Package — included so you can evaluate depth, format, and clinical fit before purchasing or licensing.

Every excerpt below is pulled directly from the course materials. What you see here is representative of the level of specificity, clinical grounding, and ready-to-use format throughout the full course.

The first three excerpts are from the Clinical Operations Package (Prescriber Track). The fourth is from the certificate course RN workbook — the same case-study and reflection format used in every module across both tracks.

From the Playbook

The CLEAR Framework

Fill in before every prior authorization submission.

Element
Fill In
C
Clinical Indication
Diagnosis + ICD-10 + severity + objective findings
L
Line of Therapy
Every prior drug: name, dose, dates, outcome, why stopped
E
Evidence Base
Guideline name + year + specific recommendation
A
Alternative Exclusion
Why formulary alternatives won't work for THIS patient
R
Risk of Delay
Clinical consequences of denial: progression, hospitalization
From the Playbook

Universal Phone Opening

Use for every call — payer, pharmacy, or specialty pharmacy.

Copy-paste ready script
"This is [Name, Credential], calling to [purpose]. Before we begin, may I have your name, reference number, and the best fax for any written submissions?"

Write down: name · reference number · fax · time — every call, every time.

From the Playbook·Prior Authorization Documentation Framework

The CLEAR Framework

Complete before every prior authorization submission. Each element maps directly to what payer reviewers look for — and what's missing from most denials.

Element
What to document
C

Clinical Indication

Why this drug, for this patient

Diagnosis + ICD-10 + severity + objective findings

L

Line of Therapy

The treatment history that got you here

Every prior drug: name, dose, dates, outcome, why stopped

E

Evidence Base

The clinical authority behind the request

Guideline name + year + specific recommendation

A

Alternative Exclusion

Why the formulary option won't work

Why formulary alternatives won't work for this patient

R

Risk of Delay

The cost of a denial or slow approval

Clinical consequences of denial: progression, hospitalization

Fill in every row before submitting. Vague history is the #1 reason appeals fail.

The full Playbook includes a fillable version of this framework plus documentation templates for 22 named drug classes.

From the Toolkit

Prescriber Workstation Card

Printable, postable reference card — self-contained, no need to reference the rest of the toolkit day to day.

POST AT THIS WORKSTATION — Prescriber Workstation

Before you finish the prescription:

  • Check the real-time benefit tool — is this on formulary at the patient's tier?
  • If PA-required: complete the matching documentation template now, while history is fresh
  • Document prior failed therapies with specific dates, doses, and reasons — vague history is the #1 reason appeals fail
  • Check whether this payer/drug combo has denied before — if so, attach extra guideline support
  • Tell the patient a PA may be required and roughly how long it can take

If it's denied:

  • Confirm the denial states a specific reason — if not, that's grounds to escalate immediately
  • Request peer-to-peer with a same-specialty reviewer within days, not weeks
  • Appeal. 82% of filed appeals succeed — don't skip this step for lack of time

The full Toolkit includes print-ready versions of all workstation cards, templates, and smart phrases.

From the Certificate Course·Module 3: Payer Landscape — RN Workbook

Case Study: Mrs. Chen's Insulin

A structured case study and reflection prompt from the RN Track workbook — the format used throughout the certificate course.

The situation

Mrs. Chen is a 71-year-old Medicare beneficiary with Type 2 diabetes. Her physician recently switched her from a brand-name insulin she has used for six years to a biosimilar insulin on the new formulary. She calls the clinic in tears: the pharmacy is charging her $112 for the biosimilar — more than she paid for the brand. She says she cannot afford it and is rationing her doses.

Her Medicare plan year reset on January 1. She is in the deductible phase. The $35/month Medicare insulin cap applies only to covered Part D insulins — and her plan's formulary lists this biosimilar under a specialty tier with a separate cost-sharing structure.

Workbook reflection question

What does a prescriber owe their patient when a formulary change creates an unintended cost barrier — and what is the RN's role in identifying and escalating it before the patient rations or stops?

Consider:

  1. What payer-specific information would you gather before calling the plan on Mrs. Chen's behalf?
  2. Which Medicare rule applies here, and why doesn't the $35 cap resolve this situation?
  3. Draft one sentence you would say to Mrs. Chen right now to prevent her from rationing tonight.

Every module in the certificate course includes a workbook with case studies, reflection questions, and a role-specific quiz.

From the certificate course — Module 4 preview

The January Reset: A Predictable Crisis

This is an actual content slide from Module 4 of the certificate course. Every module follows this format — a focused visual that frames the clinical problem, paired with a workbook prompt that turns the concept into an immediate action step.

Course slide: The January Reset — A Predictable Crisis. Module 4 of the MedAccessCE certificate course.

What this teaches: Every January, patients hit their deductible reset simultaneously — leading to a predictable spike in abandoned prescriptions. This slide gives prescribers and RNs the framing to anticipate the crisis and intervene before the patient leaves the pharmacy empty-handed.

Ready to equip your team?

The full Playbook and Toolkit go far deeper — covering drug shortages, pharmacy deserts, rare disease funding, inpatient-to-outpatient transitions, and more. Available individually or as part of the Clinical Operations Package.